Trial NCT01444118

View at ClinicalTrials.gov 
Org. Study IDs: BV-NSCLC-001

Last trial update was posted on 2015-07-22

MeSH Interventions

Cyclophosphamide Monatide (IMS 3015) Vaccines

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

The early termination is not related to safety/toxicity but to initiate new Phase III with biomarker to enrich population & to further strengthen OS benefit

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID